Orthopedic Intra-Articular Hyaluronic Acid (IAHA) Injection Market
Description
Orthopedic Intra-Articular Hyaluronic Acid (IAHA) Injection Market Size, Share, By Product Type (Low Molecular Weight HA, Medium Molecular Weight HA, and High Molecular Weight HA), Strength (2–5 mg/mL, 5–10 mg/mL, 10–20 mg/mL, and Others), Indications (Osteoarthritis (OA), Soft Tissue Injuries, Sports-Related Joint Injuries, and Others), Osteoarticular condition (Inflammatory, and Degenerative), End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers (ASCs), and Others), and Region - Trends, Analysis, and Forecast till 2035
The Orthopedic Intra-Articular Hyaluronic Acid (IAHA) Injection Market Report offers an in-depth exploration of emerging market trends, driving factors, challenges, and key segments that shape the industry. It includes a thorough examination of regulatory frameworks, company profiles, and the latest industry developments. The report delves into product development, positioning strategies, and the impact of new technologies on the market landscape. By identifying challenges and opportunities, the report provides a detailed roadmap for market growth.
A natural material found in hyaluronic acid-format fluid is injected into a joint as part of an orthopedic intra-articular hyaluronic acid (IAHA) injection. This procedure is most frequently used to treat patients with persistent osteoarthritis in order to reduce discomfort and increase mobility. Due to the growing prevalence of osteoarthritis and rising obesity rates among the elderly population, which exacerbate joint problems, the market for orthopedic intra-articular hyaluronic acid (IAHA) injections is expanding. Because IAHA injections offer efficient pain relief with fewer side effects, there is also a growing need for less invasive, non-surgical pain treatment options. Long-lasting and single-fasting injections, such as advancements in hyaluronic acid, better outpatient treatment, and rising health care costs, are in addition to raising patient and practitioner knowledge.
Report Highlights:
Orthopedic intra-articular hyaluronic acid (IAHA) injection market size is valuated at USD 2.4 Billion in 2025.
Target market size is estimated to be valuated at USD 3.9 Billion by 2035 and at a CAGR of 5.5%.
High molecular weight (HMW) hyaluronic acid injections account for the biggest portion of the orthopedic (IAHA) market share, by product type.
Based on the strength, the orthopedic intra-articular hyaluronic acid (IAHA) injection market is presently dominated by high-concentration HA injections (10–20 mg/mL).
Osteoarthritis (OA) has the biggest orthopedic intra-articular hyaluronic acid (IAHA) injection market share, on the account of indications.
On the osteoarticular condition, degenerative osteoarticular disorders including osteoarthritis represent the biggest orthopedic intra-articular hyaluronic acid (IAHA) injection market share.
The orthopedic intra-articular hyaluronic acid (IAHA) injection market is dominated by hospitals on the basis of end user.
North America is dominating region in the orthopedic intra-articular hyaluronic acid (IAHA) injection market.
The Europe region is seeing the fastest growth in the orthopedic intra-articular hyaluronic acid (IAHA) injection market share.
Key Highlights:
Importance of Orthopedic Intra-Articular Hyaluronic Acid (IAHA) Injection:
For patients with osteoarthritis in particular, orthopedic intra-articular hyaluronic acid (IAHA) injection is crucial since it provides a less invasive, non-surgical option for treating joint discomfort. IAHA injections help people who have not reacted well to oral drugs or physical therapy by improving mobility, reducing discomfort, and improving quality of life by restoring the viscosity and cushioning effect of joint fluid. In both the early and intermediate phases of joint degeneration, it is a useful therapy choice since it also helps postpone the need for joint replacement surgery.
Segmentation:
By Product Type:
Anika Therapeutics, Inc.
Zimmer Biomet
Johnson & Johnson
Diaco Biofarmaceutici srl
LG Chem
Bioventus LLC
IBSA Poland sp. z o.o.
Fidia Pharma USA Inc.
Ferring
SEIKAGAKU CORPORATION
MDT Int’l. SA.
Biotech
Maxigen Biotech Inc.
i+Med
Bioiberica S.A.U.
What You’ll Gain from This Report:
Key Questions Answered in the Report.
1. What was the Orthopedic Intra-Articular Hyaluronic Acid (IAHA) Injection Market size in 2025?
2. What is projected growth rate of the Orthopedic Intra-Articular Hyaluronic Acid (IAHA) Injection Market during 2025-2035?
3. What are the key factors driving the Orthopedic Intra-Articular Hyaluronic Acid (IAHA) Injection Market growth?
4. What are leading players in the Orthopedic Intra-Articular Hyaluronic Acid (IAHA) Injection Market?
5. What are the key regions analyzed in the Orthopedic Intra-Articular Hyaluronic Acid (IAHA) Injection Market?
6. Which region is dominating in the Orthopedic Intra-Articular Hyaluronic Acid (IAHA) Injection Market?
The Orthopedic Intra-Articular Hyaluronic Acid (IAHA) Injection Market Report offers an in-depth exploration of emerging market trends, driving factors, challenges, and key segments that shape the industry. It includes a thorough examination of regulatory frameworks, company profiles, and the latest industry developments. The report delves into product development, positioning strategies, and the impact of new technologies on the market landscape. By identifying challenges and opportunities, the report provides a detailed roadmap for market growth.
A natural material found in hyaluronic acid-format fluid is injected into a joint as part of an orthopedic intra-articular hyaluronic acid (IAHA) injection. This procedure is most frequently used to treat patients with persistent osteoarthritis in order to reduce discomfort and increase mobility. Due to the growing prevalence of osteoarthritis and rising obesity rates among the elderly population, which exacerbate joint problems, the market for orthopedic intra-articular hyaluronic acid (IAHA) injections is expanding. Because IAHA injections offer efficient pain relief with fewer side effects, there is also a growing need for less invasive, non-surgical pain treatment options. Long-lasting and single-fasting injections, such as advancements in hyaluronic acid, better outpatient treatment, and rising health care costs, are in addition to raising patient and practitioner knowledge.
Report Highlights:
Orthopedic intra-articular hyaluronic acid (IAHA) injection market size is valuated at USD 2.4 Billion in 2025.
Target market size is estimated to be valuated at USD 3.9 Billion by 2035 and at a CAGR of 5.5%.
High molecular weight (HMW) hyaluronic acid injections account for the biggest portion of the orthopedic (IAHA) market share, by product type.
Based on the strength, the orthopedic intra-articular hyaluronic acid (IAHA) injection market is presently dominated by high-concentration HA injections (10–20 mg/mL).
Osteoarthritis (OA) has the biggest orthopedic intra-articular hyaluronic acid (IAHA) injection market share, on the account of indications.
On the osteoarticular condition, degenerative osteoarticular disorders including osteoarthritis represent the biggest orthopedic intra-articular hyaluronic acid (IAHA) injection market share.
The orthopedic intra-articular hyaluronic acid (IAHA) injection market is dominated by hospitals on the basis of end user.
North America is dominating region in the orthopedic intra-articular hyaluronic acid (IAHA) injection market.
The Europe region is seeing the fastest growth in the orthopedic intra-articular hyaluronic acid (IAHA) injection market share.
Key Highlights:
- In May 2021, JOYCLU 30mg Intra-articular Injection (generic name: diclofenac etalhyaluronate sodium; “JOYCLU”) is a joint function improvement agent that Ono Pharmaceutical Co., Ltd. and Seikagaku Corporation announced Ono has introduced. In March 2021, Seikagaku was granted manufacturing and marketing approval in Japan for this product. With an intra-articular injection administered once every four weeks, JOYCLU is authorized to treat osteoarthritis in the hip and knee joints and is anticipated to alleviate its symptoms.
Importance of Orthopedic Intra-Articular Hyaluronic Acid (IAHA) Injection:
For patients with osteoarthritis in particular, orthopedic intra-articular hyaluronic acid (IAHA) injection is crucial since it provides a less invasive, non-surgical option for treating joint discomfort. IAHA injections help people who have not reacted well to oral drugs or physical therapy by improving mobility, reducing discomfort, and improving quality of life by restoring the viscosity and cushioning effect of joint fluid. In both the early and intermediate phases of joint degeneration, it is a useful therapy choice since it also helps postpone the need for joint replacement surgery.
Segmentation:
By Product Type:
- Low Molecular Weight HA
- Medium Molecular Weight HA
- High Molecular Weight HA
- 2–5 mg/mL
- 5–10 mg/mL
- 10–20 mg/mL
- Others
- Osteoarthritis (OA)
- Soft Tissue Injuries
- Sports-Related Joint Injuries
- Inflammatory
- Degenerative
- Hospitals
- Orthopedic Clinics
- Ambulatory Surgical Centers (ASCs)
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- Indonesia
- Malaysia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
Anika Therapeutics, Inc.
Zimmer Biomet
Johnson & Johnson
Diaco Biofarmaceutici srl
LG Chem
Bioventus LLC
IBSA Poland sp. z o.o.
Fidia Pharma USA Inc.
Ferring
SEIKAGAKU CORPORATION
MDT Int’l. SA.
Biotech
Maxigen Biotech Inc.
i+Med
Bioiberica S.A.U.
What You’ll Gain from This Report:
- Pinpoint Lucrative Opportunities: Access granular analysis of regional and country-level markets, identifying underserved segments and optimal areas for investment and expansion.
- Navigate Market Entry with Confidence: Leverage expert frameworks to sidestep common pitfalls, accelerate your market penetration, and build a sustainable competitive advantage from day one.
- Future-Proof Your Investments: Base your long-term plans on robust, data-validated forecasts through 2035, with clear strategic checkpoints for 2025, 2026, and 2030.
- Decode the Competitive Landscape: Gain an unobstructed view of your rivals' playbooks, from their core strategies to their latest moves, allowing you to anticipate shifts and seize the initiative.
- Optimize for Profitability and Growth: Implement proven, segment-specific strategies designed to enhance operational efficiency, capture market share, and drive your bottom line.
- Harness Supply Chain Innovation: Discover how cutting-edge technologies are redefining logistics and procurement, creating new opportunities for cost reduction and value creation.
Key Questions Answered in the Report.
1. What was the Orthopedic Intra-Articular Hyaluronic Acid (IAHA) Injection Market size in 2025?
2. What is projected growth rate of the Orthopedic Intra-Articular Hyaluronic Acid (IAHA) Injection Market during 2025-2035?
3. What are the key factors driving the Orthopedic Intra-Articular Hyaluronic Acid (IAHA) Injection Market growth?
4. What are leading players in the Orthopedic Intra-Articular Hyaluronic Acid (IAHA) Injection Market?
5. What are the key regions analyzed in the Orthopedic Intra-Articular Hyaluronic Acid (IAHA) Injection Market?
6. Which region is dominating in the Orthopedic Intra-Articular Hyaluronic Acid (IAHA) Injection Market?
Table of Contents
171 Pages
- Orthopedic Intra Articular Hyaluronic Acid Iaha Injection Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Preview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Strength
- Market Snippet, By Indications
- Market Snippet, By Osteoarticular Condition
- Market Snippet, By End User
- Market Snippet, By Region
- Opportunity Map Analysis
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Product Launch
- Merger and Acquisitions
- Impact Analysis
- PEST Analysis
- Patent Analysis
- Pipeline Analysis
- Production of Hyaluronic Acid: Innovations and Challenges
- Market Segmentation, By Product Type, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Low Molecular Weight HA
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Medium Molecular Weight HA
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- High Molecular Weight HA
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Strength, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- 2–5 mg/mL
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- 5–10 mg/mL
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- 10–20 mg/mL
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Others
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Indications, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Osteoarthritis (OA)
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Soft Tissue Injuries
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Sports-Related Joint Injuries
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Others
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Osteoarticular Condition, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Inflammatory
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Degenerative
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By End User, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Orthopedic Clinics
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Ambulatory Surgical Centers (ASCs)
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Others
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Region, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Regional Trends
- North America
- Market Size and Forecast (USD Bn), By Product Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Strength, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Indications, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Osteoarticular Condition, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- U.S.
- Canada
- Asia Pacific
- Market Size and Forecast (USD Bn), By Product Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Strength, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Indications, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Osteoarticular Condition, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- China
- India
- Japan
- Australia
- Indonesia
- Malaysia
- South Korea
- Rest of Asia Pacific
- Europe
- Market Size and Forecast (USD Bn), By Product Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Strength, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Indications, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Osteoarticular Condition, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- Germany
- U.K.
- France
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
- Latin America
- Market Size and Forecast (USD Bn), By Product Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Strength, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Indications, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Osteoarticular Condition, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East and Africa
- Market Size and Forecast (USD Bn), By Product Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Strength, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Indications, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Osteoarticular Condition, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
